GSS logo

Genetic Signatures Limited Stock Price

ASX:GSS Community·AU$21.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

GSS Share Price Performance

AU$0.095
-0.19 (-67.24%)
AU$0.095
-0.19 (-67.24%)
Price AU$0.095

GSS Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and fair value.

2 Risks
2 Rewards

Genetic Signatures Limited Key Details

AU$19.3m

Revenue

AU$10.7m

Cost of Revenue

AU$8.6m

Gross Profit

AU$22.6m

Other Expenses

-AU$14.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.062
44.53%
-72.45%
0%
View Full Analysis

About GSS

Founded
2001
Employees
n/a
CEO
Maria Halasz
WebsiteView website
www.geneticsignatures.com

Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. The company offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, and Rubella detection kits under the EasyScreen name. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.

Recent GSS News & Updates

Recent updates

No updates